Shares of cannabis producers rise after falling after Cronos reporting. Shares of Canadian cannabis manufacturing companies on Friday mostly rose as part of the correction to a rather serious fall, which followed the publication of the quarterly report of the Cronos Group (CRON). The company's financial results for the reporting financial quarter were significantly worse than market expectations. So, in particular, the company unexpectedly reported a loss of $8.8 million, after which major analysts worsened their recommendations on these securities to “sell” from “hold”. At the same time, after having somewhat digested this information, this segment of the market again shot upward as part of the correction. An additional reason for optimism was the Ernst & Young forecast that by 2025, every fifth Canadian adult will be using marijuana, spending an average of 1.7 thousand dollars a year for this purpose. In turn, the company Tilray Inc. (TLRY) promised to strengthen its team by attracting experienced financial experts to prepare sound financial statements and strengthen internal financial control. According to financial scouts, in the coming days, shares of Canadian cannabis producers will continue their upward trend. For example, Cronos shares could rise to $19, Tilray - up to $66.5, Canopy Growth (CGC) - up to $43-43.5, Aurora Cannabis (ACB) - up to $9, Aphria (APHA) - up to $9,5 dollars.